Health Care

Grab This Once-A-Year Tax Break

Learn more about the Flexible Spending Account, a terrific tax break for anyone with regular medical expenses, from co-pays to eyeglasses.

Aetna CEO Expects Some ACA Benefits to Stay

Aetna Inc Chief Executive Officer Mark Bertolini said he expected some benefits of President Barack Obama's national healthcare reform law will stick under President-elect Donald Trump, like allowing young adults to stay on their family's health insurance.

Drug firm AstraZeneca says 3Q earnings fall 12 percent.

Anglo-Swedish drugmaker AstraZeneca says third-quarter earnings fell 12 percent as its blockbuster cholesterol drug Crestor faced its first full quarter of competition in the United States from generic alternatives.

Mylan Working to Finalize EpiPen Settlement

Generic drugmaker Mylan NV said on Wednesday it was working to finalize a settlement with the U.S. government over Medicaid rebates for its EpiPen emergency allergy treatment, adding that money set aside for the settlement led to a third quarter loss.

Mylan sees 3Q loss due to settlement for EpiPen overcharges

Drugmaker Mylan Inc. swung to a third-quarter loss, mainly due to a big settlement for overcharging the federal government for its controversial EpiPen, the emergency allergy injector whose price Mylan has repeatedly jacked up.

Embattled Drugmaker Mylan's Earnings Disappoint

Generic drugmaker Mylan NV, which is under investigation and has faced harsh criticism over steep price increases for its EpiPen emergency allergy treatment, on Wednesday reported a third quarter loss due the cost of a proposed settlement with the U.S. department of Justice and other government agencies.